A novel blood test analyzing fragments of cell-free DNA showed robust diagnostic performance for colorectal cancer across clinical subgroups, offering a promising noninvasive screening method.

Researchers have discovered that analyzing specific patterns of cell-free DNA (cfDNA) fragmentation in a simple urine sample ...

A new cfDNA-based blood test uses AI to detect bladder, prostate, and kidney cancers early, offering a faster, safer, and ...

Natera Inc., a cell-free DNA and precision medicine company, has acquired Foresight Diagnostics, a leader in ultrasensitive ...

An Austin, Texas-based genetics-testing company that specializes in cell-free DNA and precision medicine has acquired Foresight Diagnostics Inc., a Boulder-based cancer-diagnostics company.

An Arizona veteran who learned he has ALS is exploring a new blood test that researchers at UCLA are studying.

Dear Doctor, I am negative, and she is positive, so I had another test, which proved that she did not have sickle cell disease, and so we went ahead and got married.

Cancer usually grows quietly for years before it causes pain, bleeding or weight loss. By the time symptoms appear, disease may already have spread, making treatment harder and survival chances lower.

With a new study in the journal Cell, researchers at Stanford University and Stockholm University have contributed to ...

Researchers have discovered that analyzing specific patterns of cell-free DNA (cfDNA) fragmentation in a simple urine sample can ...